Organometal compounds affect many enzymes, especially those containing SH-groups as acyl-and acetyltransferases involved in lysophospholipid reacylation. In HL-60 cells, organotin and -lead compounds stimulate phospholipase A2 activity, contributing thus to increase the level of lysophospholipids. In the present study, we have tested whether paf-acether (paf) biosynthesis was affected by treatment with triethyllead (Et3PbCI) in HL-60 cells. Et3PbCI inhibits the incorporation of exogenous arachidonic acid in the presence of high (1 50 pM) but not low concentrations (< 1 pM). High concentrations of the lead compound are unable to induce paf formation by itself, however, lower concentrations (< 10 pM) acted synergistically with TPA or fMLP to stimulate paf formation. Whereas unstimulated cells produced 0.4 pmole paf/2 x 106 cells, the stimulation with low fMLP (0.1 pM) resulted in the synthesis of 1.7 pmole and with low TPA (2 ng/ml) in 0.5 pmole paf. Preincubation of the cells with 10 pM Et3PbCI for 20 to 30 min increased the amount of paf formed by these cells to 3.3 pmole after treatment with 0.1 pM fMLP and 1.5 pmole after TPA. Furthermore, the results showed an inhibition of acetyltransferase (the key enzyme of paf synthesis) by the high and not by low concentrations of the lead compound. We conclude that low concentrations of Et3PbCI (< 10 pM) may act as a synergistic inducer of paf synthesis initiated via a receptor-coupled stimulation. -Environ Health Perspect 102(Suppl 3): 331-334 (1994).
Introduction
The balance of deacylation and reacylation of cellular membrane phospholipids plays an important role in many cell types as well as in multiple physiological and pathological processes. More and more investigations have shown that environmental toxicants as heavy metal compounds affect this sensitive mechanism within human blood platelets (1) (2) (3) (4) , macrophages (5), granulocytes (6) (7) (8) , as well as in fibroblasts (9) . These xenobiotics enhance the deacylation either via the activation of phospholipase A2 (2, 7, 8) or the inhibition of fatty acid-CoA synthetase or lysophospholipid acyltransferase (4) (5) (6) lipid mediators. Another important pathway coupled to this deacylation-reacylation cycle is involved in paf production, a very potent mediator of anaphylaxis and inflammation (10) : The acetylation of lyso paf-acether (lyso paf, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by the activity of the key enzyme lyso paf:acetyl-CoA acetyltransferase mediates the biosynthesis of paf (11) (12) (13) .
As mentioned above, the release of arachidonic acid from phospholipids is stimulated by organometals and its reacylation into lysophospholipids by acyltransferases is inhibited. It is well documented that these effects induce an increase of arachidonic acid as well as of its metabolites, the eicosanoids, but little is known about the destiny of the increased amount of lysophospholipids. To assess the possible role of these lysophospholipids in the biosynthesis of paf we examined the activity of acetyltransferase and the amount of paf produced after treatment with triethyllead (Et3PbCl). Our (1 mg/ml) and penicillin (1000 IU/ml uptake of the fatty acid within the first 60 min, 50% of the total radioactivity was incorporated into the phospholipids (the bulk was found in PC) and 16% into the neutral lipids ( Figure IA) . As compared with vehicle-treated control cells, Et3PbCl inhibited the incorporation of exogenous arachidonic acid into various lipid classes only when added in high concentrations ( Figure IC) . One hundred times lower concentrations reduced the incorporation into the different lipid classes to only a minor not significant extent (Figure 1 B) . Preincubations with the same low concentration for 24 hr before exogenous arachidonic acid was added showed no detectable effect (data not shown). It is apparent from Figure 1C amounts of paf were formed when cells were stimulated with fMLP as well as TPA ( Figure 3 ). The paf formation was nearly unaffected in cells treated either with 10 pM or 100 pM Et PbCl (Figure 3 ).
In the next set ofWexperiments we incubated the HL-60 cells with the low amounts of the three substances, 0.1 pM fMLP, 2 ng/ml TPA, or 10 pM Et3PbCl. As shown in Figure 4 (open bars) only fMLP (1.7 pmole/2 x 106 cells) induced a significant production of paf. Although Et3PbCl alone was not able to stimulate paf formation it exhibited a synergistic action together with fMLP or TPA. Furthermore, it is apparent that together with fMLP a stimulation could be detected only when Et3PbCl was added at first whereas the synergism with TPA was sequence-independent ( Figure 4 ). More than the additive effect in paf stimulation by the synergistic action of Et3PbCl and fMLP was observed. Moreover, Et3PbCl enhanced the paf production synergistically together with low TPA to 145% of the stimulatory effect of high TPA alone (compare Figure 3 ).
Discussion
Human neutrophils and other cell types respond to exogenous stimuli, e.g., TPA, A 23187, or fMLP, with a rapid increase of free arachidonic acid. This is an important metabolic pathway because the enzyme that is involved, the phospholipase A2 (PLA2), also hydrolyses 1-0-alkyl-2-arachidonoylsn-glycero-3-phosphocholine (14) to yield lyso paf (15) . The lyso paf formed may be acetylated via acetyltransferase to form paf or reacylated with fatty acid residues (16) . Therefore, the balance between these two transferase activities plays an important role in paf formation. The incorporation of fatty acids into lysophospholipids could be prevented by the inhibition of reacylation via the acylCoA-synthetase and the lysophospholipid acyltransferase. It has been shown that not only organomercury compounds such as ethylmercurithiosalicylate (3, 5, 6) , MeHgCl (4) , and p-hydroxymercurisalicylat (9) affect these enzymes, but also organolead inhibits the reincorporation of exogenous arachidonic acid (7) (Figure 1 ). This may lead to the assumption that the stimulated activity of the PLA2 rises the amount of lyso paf as well as of arachidonic acid when cells were treated with the organometal compounds. We tested therefore the effect of Et3PbCl, a severely toxic organometal compound (8) , on the activity of acetyltransferase. This enzyme is located at the same cellular site as the acyltransferase within the HL-60 cells (13) . After stimulation of differentiated HL-60 cells with A 23187, the enzyme activity increased 3-to 4-fold (17) or, as shown here, 4-to 5-fold (Figure 2) over the values observed in the resting state. As demonstrated for the reacylation pathway (18) the acetylation of lyso paf is inhibited within the same con- centration-range ( Figure 2 ). In this connection it is now clear that high concentrations (50-100 1iM) of Et3PbCl that induce a substantial loss of arachidonic acid from phospholipids and prevents the reacylation of the lysophospholipids not lead to an increased paf synthesis as expected ( Figure 3 ). This is the consequence of the concomitant inhibition of acetyltransferase by high lead concentrations, whereas low concentrations of Et3PbCl had no effect. On the other hand, these low concentrations (<10 pM) have still an effect on the lipid metabolism in these cells (7 (20) . To trigger the full cellular response, additionally receptor-operated antigen challenge was necessary.
In HL-60 cells and many other cell types, especially those of the hematopoetic system, the deacylation-reacylation cycle plays an important role in the regulation of free arachidonic acid concentration as well as of paf formation. The eicosanoids, metabolites of the arachidonic acid, and paf are second messenger molecules with a multitude of functions, intra-as well as intercellular. Particularly neutrophilic granulocytes are able to interact with various cell types, such as macrophages, mast cells, platelets, polymorphonuclear leukocytes, and many others, e.g., via their products of the phospholipase A2 cascade (21) and the subsequently formed paf (10, 22) .
The results presented here demonstrate that low concentrations of the organolead compound, Et3PbCl, sensitize differentiated HL-60 cells against subsequent stimulation by other agents. These low doses do not inhibit the acyltransferase as well as the acetyltransferase but enhance the activity of the PLA2, thereby increasing the rate of deacylation-reacylation within the remodeling cycle. As a result of such an enhanced activity within this cycle is the increased paf formation after additional stimulation. In the case of higher amounts of Et3PbCl only arachidonic acid and its metabolites could be detected because the inhibition of acetyltransferase prevents the paf synthesis. It seems that this mechanism is not only relevant in vitro but also in vivo within occupationally lead-exposed workers (23) . In this study it is well documented that in leukocytes of lead-exposed workers the amount of arachidonic acid is significantly increased and the production of LTB4 after stimulation with fMLP is significantly higher than in the control group. We described earlier comparable effects on the arachidonic acid metabolism for other organometals as well (8, 18) and the assumption could be made that these compounds may lead in vivo to increase in the level of lipid mediators, eicosanoids and paf, which are considered as potent mediators of inflammatory, allergic, and pseudoallergic reactions (21, 23) .
